A

Pegloticase is a pegylated recombinant uricase approved specifically for patients with chronic refractory gout to rapidly lower serum urate levels and resolve tophi, and it is not indicated for psoriatic arthritis, rheumatoid arthritis, or paralytic ileus [Shannon 2012, PMID 22395256; Schlesinger 2020, PMID 32620200].